Biological
SCT800
SCT800 is a biological therapy with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_1
1
33%
Ph phase_3
1
33%
Ph phase_4
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 11 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)
Trials by Status
recruiting133%
unknown267%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_4
ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
NCT05888870
unknownphase_3
Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A
NCT02921945
unknownphase_1
Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A
NCT02888223
Clinical Trials (3)
Showing 3 of 3 trials
NCT05888870Phase 4
ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
NCT02921945Phase 3
Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A
NCT02888223Phase 1
Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A
All 3 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 3